IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, featuring promising developments here across several professional medical and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, extra reputable option for therapeutic use